“…1,2 Among these examples, polysaccharides such as HA, dextran, pullulan, and heparin are responsible to improve the solubility, dispersibility, and biocompatibility of nanohybrids. 3 Moreover, cationic polysaccharide CS can be used to deliver genes. 4 To realize biocompatibility and active targeting, we utilized HA to construct polysaccharide−inorganic nanohybrids.…”
Section: Nanohybrids Fabricated By Surface Modificationmentioning
confidence: 99%
“…Polysaccharides can be modified on the surface of the as-synthesized inorganic nanoparticles through chemical bonding or self-assembly strategy to construct nanohybrids. , Among these examples, polysaccharides such as HA, dextran, pullulan, and heparin are responsible to improve the solubility, dispersibility, and biocompatibility of nanohybrids . Moreover, cationic polysaccharide CS can be used to deliver genes .…”
Section: Nanohybrids Fabricated By Surface Modificationmentioning
confidence: 99%
“…Polysaccharide-based hybrid hydrogels have been recognized as promising candidates for tissue engineering . Polysaccharides forming hydrogels can be alginate, CS, HA, chondroitin sulfate, dextran, or several kinds of polysaccharides. , Versatile types of hybrid hydrogels composed of polysaccharides and inorganic nanoparticles such as alginate-Au@Pt, alginate-bioactive glass, CS-MoS 2 , HA-SiSr, and chondroitin sulfate-bioactive glass hydrogels have been reported to realize wound healing, bone regeneration or myocardial repair. For example, hybrid hydrogels composed of alginate and neodymium-doping bioactive glass can be used for burn tissue repair .…”
Section: Versatile Hybrid Systems Of Polysaccharides
and Inorganic Na...mentioning
confidence: 99%
“…Hybrids composed of polysaccharides and inorganic nanoparticles have attracted increasing attention in the biomedical field due to their satisfying performance. − As an important type of natural polymers readily available from renewable sources (plants, animals and microbes), polysaccharides are composed of glucopyranose units which are joined covalently through glucosidic bands, with various confirmations, including random coil, helix, worm-like, and aggregate . In addition, they possess favorable biocompatibility, stability, bioactivity, and abundant active groups availability for chemical modification, which are considered as ideal candidates to fabricate multifunctional platforms for diverse biomedical applications. , On the other side, inorganic nanoparticles are widely utilized based on their unique physicochemical properties .…”
“…1,2 Among these examples, polysaccharides such as HA, dextran, pullulan, and heparin are responsible to improve the solubility, dispersibility, and biocompatibility of nanohybrids. 3 Moreover, cationic polysaccharide CS can be used to deliver genes. 4 To realize biocompatibility and active targeting, we utilized HA to construct polysaccharide−inorganic nanohybrids.…”
Section: Nanohybrids Fabricated By Surface Modificationmentioning
confidence: 99%
“…Polysaccharides can be modified on the surface of the as-synthesized inorganic nanoparticles through chemical bonding or self-assembly strategy to construct nanohybrids. , Among these examples, polysaccharides such as HA, dextran, pullulan, and heparin are responsible to improve the solubility, dispersibility, and biocompatibility of nanohybrids . Moreover, cationic polysaccharide CS can be used to deliver genes .…”
Section: Nanohybrids Fabricated By Surface Modificationmentioning
confidence: 99%
“…Polysaccharide-based hybrid hydrogels have been recognized as promising candidates for tissue engineering . Polysaccharides forming hydrogels can be alginate, CS, HA, chondroitin sulfate, dextran, or several kinds of polysaccharides. , Versatile types of hybrid hydrogels composed of polysaccharides and inorganic nanoparticles such as alginate-Au@Pt, alginate-bioactive glass, CS-MoS 2 , HA-SiSr, and chondroitin sulfate-bioactive glass hydrogels have been reported to realize wound healing, bone regeneration or myocardial repair. For example, hybrid hydrogels composed of alginate and neodymium-doping bioactive glass can be used for burn tissue repair .…”
Section: Versatile Hybrid Systems Of Polysaccharides
and Inorganic Na...mentioning
confidence: 99%
“…Hybrids composed of polysaccharides and inorganic nanoparticles have attracted increasing attention in the biomedical field due to their satisfying performance. − As an important type of natural polymers readily available from renewable sources (plants, animals and microbes), polysaccharides are composed of glucopyranose units which are joined covalently through glucosidic bands, with various confirmations, including random coil, helix, worm-like, and aggregate . In addition, they possess favorable biocompatibility, stability, bioactivity, and abundant active groups availability for chemical modification, which are considered as ideal candidates to fabricate multifunctional platforms for diverse biomedical applications. , On the other side, inorganic nanoparticles are widely utilized based on their unique physicochemical properties .…”
“…The vacuoles that originated persist, grow, and eventually explode in the tissue, producing localized thermal and cytotoxic effects, including hyperoxidative cellular structural damage and acoustodynamic effects such as shearing stress and shock waves. At the same time, the bursting of the vacuole causes cell membrane disruption, allowing drugs and other substances to enter the cell passively. , However, a single SDT has limited effect on tumor inhibition. , Relevant studies have revealed that ultrasound can be used to increase the chemotherapeutic drug uptake by cancer cells, thus reducing the poisonous side effects on healthy cells and organizations. , Despite the anticipated favorable therapeutic effect of combining chemotherapy and SDT, the efficacy of treatment is compromised primarily due to tumor hypoxia resulting from aberrant cancer cell proliferation and distorted tumor vasculatures. , SDT works by turning oxygen into deadly singlet oxygen ( 1 O 2 ) causing cells; thus, the hypoxic environment of the tumor greatly limited oxygen utilization and reduced the efficiency of SDT. , In addition, the hypoxia condition in the tumor will trigger the hypoxia-inducible factor α (HIF-1α) and subsequently increase the expression of P-glycoprotein (P-gp), thereby inducing the transportation of chemotherapeutic drugs outside the cancer cells and leading to drug resistance. − Therefore, tumor hypoxia is of paramount importance in furthering the therapeutic effect of SDT. Recent studies have revealed that manganese oxide (MnO 2 ) can produce oxygen by reacting with extra hydrogen dioxide in the microenvironment of tumor to alleviate hypoxia. − For efficient SDT and chemotherapy, the fabrication of nanocarriers with a high drug loading capacity is crucial.…”
Sonodynamic therapy (SDT) and chemotherapy have received
great
attention as effective methods for tumor treatment. However, the inherent
hypoxia of the tumor greatly hinders its therapeutic efficacy. In
this work, a tumor microenvironment-responsive biodegradable nanoplatform
SiO2–MnO2–PEG–Ce6&DOX
(designated as SMPC&D) is fabricated by encapsulating manganese
oxide (MnO2) into silica nanoparticles and anchoring poly(ethylene
glycol) (PEG) onto the surface for tumor hypoxia relief and delivery,
then loaded with sonosensitizer Chlorin e6 (Ce6) and chemotherapeutic
drug doxorubicin (DOX) for hypoxic tumor treatment. We evaluated the
physicochemical properties of SMPC&D nanoparticles and the tumor
therapeutic effects of chemotherapy and SDT under ultrasound stimulation in vitro and in vivo. After endocytosis
by tumor cells, highly expressed glutathione (GSH) triggers biodegradation
of the nanoplatform and MnO2 catalyzes hydrogen peroxide
(H2O2) to generate oxygen (O2), thereby
alleviating tumor hypoxia. Depleting GSH and self-supplying O2 effectively improve the SDT efficiency both in vitro and in vivo. Ultrasonic stimulation promoted the
release and cellular uptake of chemotherapy drugs. In addition, the
relieved hypoxia reduced the efflux of chemotherapy drugs by downregulating
the expression of the P-gp protein, which jointly improved the effect
of chemotherapy. This study demonstrates that the degradable SMPC&D
as a therapeutic agent can achieve efficient chemotherapy and SDT
synergistic therapy for hypoxic tumors.
Currently, the secondary development and modification of clinical drugs has become one of the research priorities. Researchers have developed a variety of TME‐responsive nanomedicine carriers to solve certain clinical problems. Unfortunately, endogenous stimuli such as reactive oxygen species (ROS), as an important prerequisite for effective therapeutic efficacy, are not enough to achieve the expected drug release process, therefore, it is difficult to achieve a continuous and efficient treatment process. Herein, a self‐supply ROS‐responsive cascade polyprodrug (PMTO) was designed. The encapsulation of the chemotherapy drug mitoxantrone (MTO) in a polymer backbone could effectively reduce systemic toxicity when transported in vivo. After PMTO was degraded by endogenous ROS of the TME, another part of the polyprodrug backbone became cinnamaldehyde (CA), which can further enhance intracellular ROS, thereby achieving a sustained drug release process. Meanwhile, due to the disruption of the intracellular redox environment, the efficacy of chemotherapy drugs is enhanced. Finally, the anticancer treatment efficacy was further enhanced due to the mild hyperthermia effect of PMTO. In conclusion, the designed PMTO demonstrated remarkable antitumor efficacy, effectively addressing the limitations associated with MTO.This article is protected by copyright. All rights reserved
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.